2009-August Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Sun Aug 2 19:43:03 2009
Ending: Mon Aug 31 16:46:03 2009
Messages: 113

• [Ip-health] Who voted for Big Pharma's biogenerics proposal   Sarah Rimmington
• [Ip-health] Recap on the House vote on Biosimilars   James Love
• [Ip-health] Brazil producing osetalmivir   Gabriela Chaves
• [Ip-health] Joint Statement of Consumer Grps re adoption of Biogenerics Amendment to U.S. Health Care Reform Legislation   Sarah Rimmington
• [Ip-health] New Paper: Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?   Sarah Rimmington
• [Ip-health] More Articles about Biotech drug lobbying/lobbyists   Sarah Rimmington
• [Ip-health] THE NEW VENEZUELAN PATENT POLICY AND ACCESS TO MEDICINES   David Vivas
• [Ip-health] Los Angeles Times: Obama gives powerful drug lobby a seat at healthcare table   Thiru Balasubramaniam
• [Ip-health] National Journal: Roche Quits PhRMA And Joins BIO   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: US House Panel Backs Exclusivity for Biologic Drugs   Thiru Balasubramaniam
• [Ip-health] Emerging market success doesn't come easy for Big Pharma   Sarah Rimmington
• [Ip-health] Toronto Star editorial: AIDS drugs vs. red tape   Thiru Balasubramaniam
• [Ip-health] Business Standard: India may move WTO to protest drug seizures   Thiru Balasubramaniam
• [Ip-health] LA Times: Obama gives powerful drug lobby a seat at healthcare table   Sarah Rimmington
• [Ip-health] Lula wants a meeting with laboratories to discuss vaccines for the swine flu   Gabriela Chaves
• [Ip-health] The hidden truth behind drug company profits   Ira Glazer
• [Ip-health] Agreement between MERCOSUR and EU becomes a priority   Gabriela Chaves
• [Ip-health] Flu: Kirchner and Barchelet want to suspend patents   Gabriela Chaves
• [Ip-health] For Patients Across America, Time Has Run Out   Nicholas Fitzgerald
• [Ip-health] Wall Street Journal: India Prepares EU Trade Complaint   Thiru Balasubramaniam
• [Ip-health] Thailand Outrageous Intellectual Property Strategy   Kar K.
• [Ip-health] NYT on White House compromise with PhRMA   Emi Maclean
• [Ip-health] Flu: Kirchner and Barchelet want to suspend patents   Ken Shadlen
• [Ip-health] Flu: Kirchner and Barchelet want to suspend patents   Biotech. Info. Inst.
• [Ip-health] James Love in the Huffington Post: The White House Deal with Big Pharma   Thiru Balasubramaniam
• [Ip-health] Daily Mirror (Sri Lanka)- Trust, ethics and spurious medicine   Terri - Louise Beswick
• [Ip-health] James Love in the Huffington Post: The White House Deal with Big Pharma   Karin Hay
• [Ip-health] Pharma Times: India to reimburse costs of drug shipments which avoid EU   Thiru Balasubramaniam
• [Ip-health] New York Times: Democrats Say No to Cost Cap for Drug Manufacturers   Thiru Balasubramaniam
• [Ip-health] Financial Times: India warns EU on generic drugs seizure   Thiru Balasubramaniam
• [Ip-health] WSJ: The White House buys Big =?windows-1252?Q?Pharma=92s_sile?= =?windows-1252?Q?nce?=   robert weissman
• [Ip-health] NYT: Obama Reverses Stand on Drug Industry Deal (Sort Of. Maybe.)   robert weissman
• [Ip-health] Indy Star: Free meds for the needy: Good policy or good PR?   Sarah Rimmington
• [Ip-health] NYT: Is Obama Punking Us?   Sarah Rimmington
• [Ip-health] Intellectual Property & Vaccine Production   Sangeeta
• [Ip-health] NYT: Drug Industry to Run Ads Favoring White House Plan   robert weissman
• [Ip-health] TWN: Book Release-Negotiating a 'Development Agenda' for the WIPO   Sangeeta
• [Ip-health] Oppn to officials taking up plum posts in WTO, WIPO   Sangeeta
• [Ip-health] Pharmabiz: WIPO plans to impose 'Global Patenting System' on developing nations through PCT II   Thiru Balasubramaniam
• [Ip-health] WIPO clarification on 'Global Patenting' report on July 29   Thiru Balasubramaniam
• [Ip-health] date of commencement for Kenya Anti-Counterfeit Act, 2008   Christa Cepuch
• [Ip-health] Stories over EU seizures of low-cost drugs   Sarah Rimmington
• [Ip-health] John Barton's Passing   Sean Flynn
• [Ip-health] NYT: prescription Privacy   Sean Flynn
• [Ip-health] Climate Change, Technology Transfer and IPRs   ravi srinivas
• [Ip-health] Leaving CIEL - new email and addresses   Dalindyebo Bafana Shabalala
• [Ip-health] Unasur will ask WHO to guarantee vaccine to most vulnerable populations   Gabriela Chaves
• [Ip-health] Why do global trade agreements promote expensive drugs and cheap cigarettes?   Ellen Shaffer
• [Ip-health] Life vs Profits, The choice of Korean government!   KangAra
• [Ip-health] HAI Europe Statement: Protect legitimate trade in essential medicines   Terri - Louise Beswick
• [Ip-health] HAI Europe Statement: DG Competition Pharmaceutical Sector Inquiry- Final Report   Terri - Louise Beswick
• [Ip-health] The ThinkTank Initiative   Sisule F. Musungu
• [Ip-health] Livemint: India attractive destination for research and contract manufacturing of drugs   Suerie Moon
• [Ip-health] =?windows-1252?Q?USA_Today=3A_Drugmakers_seek_excessive_?= =?windows-1252?Q?monopolies_on_=91biologics=92?=   Sarah Rimmington
• [Ip-health] MSF interview on global response to Influenza A(H1N1) pandemic   James ARKINSTALL
• [Ip-health] Business Standard: India warned on moving WTO over drug seizures   Thiru Balasubramaniam
• [Ip-health] Terminology Matters: The Dispute between India and EU over Generic Drug Transshipments   Sophie Bloemen
• [Ip-health] India warned on moving WTO over drug seizures   Shishir K. Jha
• [Ip-health] Internal Memo Confirms Big Giveaways In White House Deal With Big Pharma   robert weissman
• [Ip-health] Signature campaign: Open letter to the President of the CII   Pranesh Prakash
• [Ip-health] Wall Street Journal editorial: Billy and the Beanstalk   Thiru Balasubramaniam
• [Ip-health] Foxnews: Drug Companies Resist White House Call to Reduce Rights to Exclusive Drug Data   Thiru Balasubramaniam
• [Ip-health] LA Times & Fierce Pharma: The latest on PhRMA deal with White House   Sarah Rimmington
• [Ip-health] Econ Justification for Open Licenses   Sean Flynn
• [Ip-health] 3 positions have just been published for the UNITAID medicines patent pool initiative   UNITAID Medicines Patent Pool Initiative
• [Ip-health] Reuters: Protesters seek cheaper Hep C drugs; criticize Roche & patents   peter maybarduk
• [Ip-health] Open Letter: 3rd Int.Conf. on Counterfeiting & Piracy   Sangeeta
• [Ip-health] Mashelkar Report   Daya Shanker
• [Ip-health] Business Standard: Govt accepts panel report against narrowing of Indian patent law   Matt Price
• [Ip-health] =?windows-1252?Q?Delhi_High_Court_Rejects_Bayer=92s_Plea_for_Patent_L?= =?windows-1252?Q?inkage?=   prathibha siva
• [Ip-health] New fact sheet: ACTA & the Drug Monopoly Enforcement Agenda   peter maybarduk
• [Ip-health] Lawyers Collective: Delhi High Court Rejects Bayer's Plea for Patent Linkage   peter maybarduk
• [Ip-health] LA Times - Obama endangering developing countries' access to affordable drugs, activists charge   James Love
• [Ip-health] Patent linkage rejected in India   Leena Menghaney
• [Ip-health] NIH chief may ask pharma to pay royalties on research   Mike Palmedo
• [Ip-health] [g-h] CPATH event Aug. 26, DC: CAFTA and Access to Meds   Ellen Shaffer
• [Ip-health] Indian court rejects patent linkage - imposes cost on Bayer for frivolous litigation   Leena Menghaney
• [Ip-health] NGOs ask industry associations to reject TRIPS Plus IP enforcement agenda in India from EMPOWER INDIA   Sangeeta
• [Ip-health] =?windows-1252?Q?Introducing_=91=91Journal_of_Clinical_Medicine_and_R?= =?windows-1252?Q?esearch_=91=91?=   jcmr journal
• [Ip-health] NIH chief may ask pharma to pay royalties on research   Biotech. Info. Inst.
• [Ip-health] LA Times: Activists say poor nations' access to affordable drugs stymied   Malini Aisola
• [Ip-health] Teva Launches "Patient First" Initiative   Year of Affordable Healthcare
• [Ip-health] =?windows-1252?Q?Novartis=92s_Big_Plans_for_Multiple_S?= =?windows-1252?Q?clerosis?=   Joana Ramos
• [Ip-health] Courts being used to stifle generic challengers   Gopa Kumar
• [Ip-health] India - Mashelkar report runs into fresh controversy   Leena Menghaney
• [Ip-health] Mashelkar report runs into fresh controversy   Gopa Kumar
• [Ip-health] Teva launches its patient-centered counterattack on biogenerics   Sarah Rimmington
• [Ip-health] WTO deputy chief urges for completion of trade talks   Indian Society For Sustainable Agriculture
• [Ip-health] Threats to Generic Drugs Policy Alarm Activists   Kar K.
• [Ip-health] Dump the Mashelkar Report : Business Standard Editorial   Gopa Kumar
• [Ip-health] The Economic Times (India) - Govt should not succumb to the WIPO pressure   Terri - Louise Beswick
• [Ip-health] CPATH Health Affairs article, CAFTA and Guatemala; event 8/26   Ellen Shaffer
• [Ip-health] Re: [spiritof1848] CPATH Health Affairs article, CAFTA and Guatemala; event 8/26   Norma Maldonado
• [Ip-health] Health Affairs - Expert Review Of Drug Patent Applications: Improving Health In The Developing World   Tahir Amin
• [Ip-health] Express Pharma - Pharmexcil to organise 'Indo-Africa Pharma Business Meet'   Terri - Louise Beswick
• [Ip-health] Indian Express Finance - 'Stringent IP enforcement will limit access to generic drugs'   Terri - Louise Beswick
• [Ip-health] =?windows-1252?Q?=91Stringent_IP_enforcement_will_limit_access_to_gen?= =?windows-1252?Q?eric_drugs=92_=3A_Financial_Express_on_Open_Letter_to_the_Pres?= =?windows-1252?Q?ident_of_e_pr_CII?=   Gopa Kumar
• [Ip-health] =?iso-8859-1?b?kVN0cmluZ2VudA==?= IP enforcement will limit access to generic =?iso-8859-1?b?ZHJ1Z3OS?= : Financial Express on Open Letter to the President of e pr CII   Shishir K. Jha
• [Ip-health] Study: Lower prices don't harm innovation   Joana Ramos
• [Ip-health] =?iso-8859-1?Q?New_Brochure_released:_AIDS_-_Normalization_in_the_North_-?= =?iso-8859-1?Q?_Tragedy_in_the_South=3F?=   Hedwig Diekwisch
• [Ip-health] CAFTA's Effect on Generic Drugs in Guatemala (New Paper by Ellen Shaffer and Joe Brenner)   Mike Palmedo
• [Ip-health] Abstracts and Registration: Global Health & Innovation Conference at Yale   Jennifer Staple-Clark
• [Ip-health] 80% of Yahoo pharmacy ads illegal: US study   Joana Ramos
• [Ip-health] Tennessean: Big Pharma wants to keep monopoly   Sarah Rimmington
• [Ip-health] Novartis challenges Gleevec patent rejection in the Supreme Court   prathibha siva
• [Ip-health] Novartis moves SC in Glivec patent case   Joana Ramos
• [Ip-health] Financial Times - Brazil ready to infringe US drug patents   Terri - Louise Beswick
• [Ip-health] Live Mint- Sharma to take up drug seizures issue with EU commissioner   Terri - Louise Beswick
• [Ip-health] Economic Times (India) - Lack of clarity in drugs Act may hit generic companies   Terri - Louise Beswick
• [Ip-health] Novartis Glivec patent case in India   Patrick Durisch
• [Ip-health] Novartis update - 31 August 2009 - Matter to come up for admission before another Bench   Julie George
• [Ip-health] MSF concern over further Novartis attack on India's patent law   Laura.McCULLAGH@geneva.msf.org
• [Ip-health] Thursday, Sept 10: KEI brownbag on Scope of Patentable Subject Matter, Bilski ruling   Malini Aisola

Last message date: Mon Aug 31 16:46:03 2009
Archived on: Mon Aug 31 15:46:04 2009

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...